NCT03676088

Brief Summary

The present study is a human, prospective, single centre, single blind, comparative controlled randomized clinical trial for the treatment of Miller's Class I, II or combination of class I and II mandibular recession and comparing the clinical outcomes prior to and 6 months after treatment. The trial is in accordance to the Consolidated Standards of Reporting Trials (CONSORT) criteria, 2010.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
6

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Nov 2016

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2016

Completed
1.5 years until next milestone

First Submitted

Initial submission to the registry

May 8, 2018

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2018

Completed
3 months until next milestone

First Posted

Study publicly available on registry

September 18, 2018

Completed
Last Updated

September 25, 2018

Status Verified

September 1, 2018

Enrollment Period

1.7 years

First QC Date

May 8, 2018

Last Update Submit

September 23, 2018

Conditions

Outcome Measures

Primary Outcomes (5)

  • Gingival recession depth (GRD)

    measured as the distance from the Cemento Enamel Junction to the gingival margin

    6 months

  • 2. Gingival Recession Width (GRW)

    measured as the distance between the mesial gingival margin and distal gingival margin

    6 months

  • Mean root coverage(MRC)

    (Baseline recession depth - 6 month recession depth/Baseline recession depth)\*100

    6 months

  • Complete root coverage(CRC)

    root coverage regarded as complete with gingival margin located at the level of Cemento Enamel Junction

    6 months

  • coverage esthetic score(RCES)

    The Aesthetic evaluation was performed according to the root coverage aesthetic score system (RES) Five Variables evaluated which are as follows: 1. Level of Gingival margin (GM) 2. Marginal Tissue Contour (MTC) 3. Soft Tissue Texture (STT) 4. Mucogingival Junction(MJ) alignment 5. Gingival Colour (GC)

    6 months

Secondary Outcomes (3)

  • probing pocket depth (PD)

    6 months

  • clinical attachment level (CAL)

    6 months

  • width of keratinized tissue (KTW)

    6 months

Study Arms (2)

Test group - rhPDGF-BB+MCAT+CTG

EXPERIMENTAL

Root coverage surgical procedure.The patients were assigned into two treatment groups (test and control). Intervention - The test group recession coverage is treated with modified coronally advanced tunnel with connective tissue graft with recombinant human platelet derived growth factor- BB

Procedure: root coverage

Control group - MCAT+CTG

ACTIVE COMPARATOR

Root coverage surgical procedure.The patients were assigned into two treatment groups (test and control). Intervention - The control group recession coverage is treated with modified coronally advanced tunnel with connective tissue graft alone

Procedure: root coverage

Interventions

root coveragePROCEDURE

recession coverage is treated with modified coronally advanced tunnel with connective tissue graft with recombinant human platelet derived growth factor- BB for Experimental: Test group and without recombinant human platelet derived growth factor- BB for Active Comparator: Control group

Also known as: root coverage with/without growth factor
Control group - MCAT+CTGTest group - rhPDGF-BB+MCAT+CTG

Eligibility Criteria

Age21 Years - 58 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Patients fulfilling the following criteria were included in the study:-
  • Two or more teeth with Miller's class I and II or combined class I and II recession defects in mandibular anteriors.
  • Age group 21-58 years.
  • Patients with healthy or treated periodontal conditions.
  • Patients willing to participate in the study.
  • Absence of uncontrolled medical conditions.
  • Patients with full mouth plaque score \</= 10%(O'Leary 1972)
  • Patients with esthetic concerns.
  • Patients with thick gingival biotype \>0.8mm

You may not qualify if:

  • Pregnant or lactating females.
  • Tobacco smoking.
  • Uncontrolled medical conditions.
  • Untreated periodontal conditions.
  • Use of systemic antibiotics in the past 3 months.
  • Patients treated with any medication known to cause gingival hyperplasia.
  • Drug and alcohol abuse
  • No occlusal interferences.
  • Patient with a known hypersensitivity to rhPDGF-BB.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Gingival Recession

Condition Hierarchy (Ancestors)

Gingival DiseasesPeriodontal DiseasesMouth DiseasesStomatognathic DiseasesPeriodontal Atrophy

Study Officials

  • Dr. Joann P George, MDS

    Krishnadevaraya College of Dental Sciences

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
Computer generated randomization sequence was obtained by the assistant. Allocation concealment was achieved using a sealed coded opaque envelope containing the treatment of the specific subject The sealed envelope containing treatment assignment was opened immediately prior to surgery to prevent surgeon bias
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: The patients were assigned into two treatment groups (test and control). The test group was treated with recombinant human Platelet Derived Growth Factor-BB and Modified Coronally Advanced Tunnel +Connective Tissue Graft whereas the control group was treated by Modified Coronally Advanced Tunnel +Connective Tissue Graft alone.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 8, 2018

First Posted

September 18, 2018

Study Start

November 1, 2016

Primary Completion

July 1, 2018

Study Completion

July 1, 2018

Last Updated

September 25, 2018

Record last verified: 2018-09

Data Sharing

IPD Sharing
Will not share